{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:17:46Z","timestamp":1775110666437,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stiff-person syndrome (SPS) is a rare neuroimmune disorder that is associated with a variety of symptoms and varying degrees of disability. SPS has multiple phenotypes and different immunological bases, and the lack of clinical awareness of these various clinical phenotypes often leads to misdiagnosis and inappropriate treatment of SPS patients in the early stage of the disease course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>We report a distinctive case of SPS with a 4-year follow-up. The patient was a 56-year-old middle-aged woman who initially presented with diplopia and atypical muscle tension. Treatment with baclofen and lorazepam showed poor efficacy, and she was once misdiagnosed with anxiety and depression as well as oculomotor nerve palsy. During the 4-year follow-up period, the patient gradually developed typical clinical manifestations and signs of SPS and was diagnosed with positive GAD antibodies. In the later stage, the patient\u2019s symptoms were exacerbated by the serotonin receptor partial agonist tandospirone; further testing revealed a significant increase in GAD antibody titer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>As the patient could not tolerate hormone pulse therapy, she was administered rituximab and two sessions of intravenous immunoglobulin (IVIG). After adjustment of the relevant treatment regimen, the patient\u2019s symptoms were significantly alleviated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SPS is relatively uncommon and prone to misdiagnosis. Therefore, we need to understand the various clinical manifestations of SPS, achieve early intervention, and thereby improve the prognosis and quality of life of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1749793","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:23:36Z","timestamp":1775107416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Aggravation of stiff-person syndrome with ophthalmoplegia after tandospirone initiation: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Kaiqi","family":"Yang","sequence":"first","affiliation":[{"name":"Graduate School of Hebei North University, Neurology Teaching and Research Office","place":["Zhangjiakou, Hebei, China"]},{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasai","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]},{"name":"Graduate School of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyuan","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Department of Neurology, Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41582-024-01012-3","article-title":"Stiff-person syndrome and related disorders - diagnosis, mechanisms and therapies","volume":"20","author":"Dalakas","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(26)01892-6","article-title":"Progressive fluctuating muscular rigidity and spasm (stiff-man syndrome): report of a case and some observations in 13 other cases","volume":"31","author":"Moersch","year":"1956","journal-title":"Proc Staff Meet MayoClin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(02)00423-9","article-title":"Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase","volume":"208","author":"Mitoma","year":"2003","journal-title":"J Neurol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.12.015","article-title":"Evidence of T-cell mediated neuronal injury in stiff-person syndrome with anti-amphiphysin antibodies","volume":"337","author":"Poh","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903728","article-title":"Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells","volume":"184","author":"Burton","year":"2010","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1246","article-title":"The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD","volume":"21","author":"Bu","year":"1994","journal-title":"Genomics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183068.42803.33","article-title":"Eye movement abnormalities in stiff person syndrome","volume":"65","author":"Economides","year":"2005","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000319725.22925.b4","article-title":"Stiff eyes in stiff-person syndrome","volume":"71","author":"Oskarsson","year":"2008","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2017.04.009","article-title":"Stiff person syndrome presenting after the initiation of buspirone","volume":"58","author":"Sablaban","year":"2017","journal-title":"Psychosomatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0028-3908(91)90176-c","article-title":"Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission","volume":"30","author":"Blier","year":"1991","journal-title":"Neuropharmacology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2020.05.095","article-title":"Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: a case report and literature review","volume":"10","author":"Patel","year":"2020","journal-title":"Ment Health Clin"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13199","article-title":"Exacerbation of stiff person syndrome by selective serotonin reuptake inhibitors","volume":"8","author":"Olszewska","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.4.462","article-title":"Specific phobia is a frequent non-motor feature in stiff man syndrome","volume":"74","author":"Henningsen","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00415-025-13226-6","article-title":"Clonidine for the management of crises in stiff-person syndrome","volume":"272","author":"Lima","year":"2025","journal-title":"J Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00415-025-13157-2","article-title":"Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review","volume":"272","author":"Pignolo","year":"2025","journal-title":"J Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403227121","article-title":"Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome","volume":"121","author":"Faissner","year":"2024","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:23:36Z","timestamp":1775107416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":18,"alternative-id":["10.3389\/fimmu.2026.1749793"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1749793","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1749793"}}